New treatment with human atrial natriuretic peptide for postoperative myonephropathic metabolic syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19766835.
- Also identified by DOI 10.1016/j.athoracsur.2009.02.075.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 49-year-old man had sudden chest pain and paralysis of the lower right limb. An acute aortic dissection was diagnosed in a computed tomography scan and the patient underwent an emergency operation. After the operation, myonephropathic metabolic syndrome developed, and human atrial natriuretic peptide was administered for 11 days until the volume of daily urine output reached at least 10,000 mL, which would facilitate limb salvage and the preservation of life without hemodialysis. This report documents that postoperative myonephropathic metabolic syndrome improved due to the strong diuretic action of human atrial natriuretic peptide without hemodialysis.
Medical subject headings
- Aortic Dissection
- Aortic Aneurysm, Thoracic
- Atrial Natriuretic Factor
- Blood Vessel Prosthesis Implantation
- Metabolic Diseases
- Rhabdomyolysis